IRIS
MORABITO, Nunziata
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.018
EU - Europa 3.435
AS - Asia 1.034
SA - Sud America 6
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 8.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.008
IE - Irlanda 1.177
SE - Svezia 1.096
CN - Cina 832
IT - Italia 391
DE - Germania 209
UA - Ucraina 143
FI - Finlandia 109
PL - Polonia 88
FR - Francia 82
GB - Regno Unito 63
SG - Singapore 63
IN - India 58
HK - Hong Kong 43
BE - Belgio 32
CA - Canada 10
TR - Turchia 9
VN - Vietnam 9
JP - Giappone 8
CZ - Repubblica Ceca 7
RU - Federazione Russa 7
NL - Olanda 6
NO - Norvegia 6
CH - Svizzera 5
BG - Bulgaria 4
CL - Cile 4
IQ - Iraq 3
KR - Corea 3
RO - Romania 3
SN - Senegal 3
BR - Brasile 2
ES - Italia 2
IR - Iran 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BT - Bhutan 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
LV - Lettonia 1
MY - Malesia 1
Totale 8.500
Salva come PNG Salva come JPEG
Città #
Dublin 1.177
Chandler 866
Nyköping 584
Jacksonville 416
Beijing 299
Ashburn 233
Princeton 215
Dearborn 194
Medford 171
Ann Arbor 156
Messina 148
Cambridge 131
Des Moines 127
Boardman 116
Bremen 105
New York 91
Warsaw 83
Wilmington 61
Jinan 60
Shenyang 60
Nanjing 52
San Mateo 45
Tianjin 37
Pune 35
Singapore 35
Woodbridge 35
Hebei 33
Brussels 32
Haikou 28
Guangzhou 26
Nanchang 25
Ningbo 25
Strasbourg 25
Zhengzhou 25
Taizhou 24
Hangzhou 23
Houston 23
Seattle 23
Catania 21
Fuzhou 19
Lancaster 18
Falls Church 15
Fremont 14
Central 11
Jiaxing 11
Milan 11
Lanzhou 10
Sheung Shui 10
Taiyuan 10
Changsha 9
Hyderabad 9
Dong Ket 8
Leawood 8
Rome 8
Helsinki 7
Norwalk 7
Brno 6
Clearwater 6
Fiumefreddo Di Sicilia 6
Rende 6
Bydgoszcz 5
Hefei 5
Monmouth Junction 5
Auburn Hills 4
Bergen 4
Chicago 4
Cosenza 4
Istanbul 4
Milazzo 4
Redwood City 4
Riva 4
Turin 4
Washington 4
Augusta 3
Fairfield 3
Florence 3
Francofonte 3
Izmir 3
Los Angeles 3
Munich 3
Pound Ridge 3
Tokyo 3
Xiangfen 3
Antalya 2
Archi 2
Ardabil 2
Caltagirone 2
Cave 2
Centuripe 2
Changle 2
Cupertino 2
Córdoba 2
Enna 2
Geesthacht 2
Glasgow 2
Hong Kong 2
Itasca 2
Jalandhar 2
Kunming 2
Lentini 2
Totale 6.193
Salva come PNG Salva come JPEG
Nome #
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 104
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 92
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 86
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 86
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 83
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 82
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 82
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 81
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 80
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 78
null 78
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 77
Role of genetic pattern on bone mineral density in thalassemic patients 75
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 74
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 71
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 70
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 70
Amylasemia in uremics: a complex interpretation 68
Recombinant erythropoietin and hypertension 68
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 67
Frailty and lipid profile in elderly hospitalized patients 66
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 65
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 65
Association between anxiety levels and osteoporosis in postmenopausal women. 65
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 63
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 63
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 63
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 63
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 61
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate. EUROPEAN UROLOGY, vol. 47; p. 575 - 581 60
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 60
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 60
Effect of genetic pattern on BMD in Thalassemic Patients: Preliminary report. 59
Flushing due to calcitonin and the opioid system 59
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 59
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 59
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 59
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 59
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 59
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 58
Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation 58
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 58
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 58
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 58
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 58
Quality of life in postmenopausal women: Which role for vitamin D? 58
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 58
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 58
THE CIRCADIAN-RHYTHM OF ERYTHROPOIETIN IN SUBJECTS WITH PRE- TERMINAL UREMIA 57
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 57
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 57
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 56
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 56
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 56
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 56
Vitamin D status is associated with anxiety levels in postmenopausal women evaluated for osteoporosis 56
Is erythropoietin-induced hypertension a phenomenon due to the intracellular Ca++ mobilisation? 55
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 55
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 55
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 55
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 54
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 54
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 54
Cardiovascular effects of raloxifene hydrochloride 53
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 53
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 53
Raloxifene and mammographic breast density 52
Anxiety levels as risk factor for osteoporosis in postmenopausal women 52
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 52
Somministrazione settimanale e giornaliera di alendronato nel trattamento dell'osteoporosi della thalassemia major. 51
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 51
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 51
Correction: In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia (Endocrine, (2019), 65, 3, (569-579), 10.1007/s12020-019-01908-x) 51
Turnover osseo e sistema osteoprotegerina/RANKL nell'osteodistrofia epatica 50
EFFETTI DELLA SOMMINISTRAZIONEDI RANELATO DI STRONZIO SUILIVELLI SIERICI DI IGF-1 IN DONNECON OSTEOPOROSI POSTMENOPAUSALE 50
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 50
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 50
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 50
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 50
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 49
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 49
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 49
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. 49
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 49
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 49
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 49
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 49
INFLUENCE OF THE TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PLASMA-CONCENTRATION OF INTERLEUKIN-1-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA IN HEMODIALYZED SUBJECTS 48
Amylasemia in uremics: a complex interpretation 48
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 48
VASCULAR CALCIFICATIONS ARE RELATED TO SCLEROSTIN AND DICKKOPF-1 IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 48
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 48
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 48
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 47
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 47
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 47
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 47
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 47
Endothelin-1 production in umbilical arteries from hypertensive pregnant women 46
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 46
Totale 5.920
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.391
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201924 0 0 0 0 0 0 0 0 0 0 0 24
2019/20201.109 85 50 14 59 13 187 124 104 39 249 147 38
2020/2021987 91 17 286 50 132 93 34 45 17 111 59 52
2021/20221.526 13 194 19 58 39 16 153 45 160 246 133 450
2022/20233.460 256 349 165 241 304 324 33 190 1.428 22 104 44
2023/2024911 67 137 43 99 66 200 36 90 6 20 17 130
Totale 8.857